• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最大化自我管理门诊静脉注射抗菌治疗途径的机会。

Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway.

机构信息

OPAT Specialist Nurse, OPAT Service, Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust.

OPAT Specialist Sister, OPAT Service, Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust.

出版信息

Br J Nurs. 2021 Jan 28;30(2):S4-S10. doi: 10.12968/bjon.2021.30.2.S4.

DOI:10.12968/bjon.2021.30.2.S4
PMID:33529119
Abstract

BACKGROUND

The University Hospitals of Leicester NHS Trust outpatient parenteral antimicrobial therapy (OPAT) service has expanded rapidly with more nurse-led direction.

AIMS

A retrospective study between 1 July 2014 and 31 December 2019 was undertaken to assess the impact of OPAT expansion on beds released for further utilisation, clinical outcomes, adverse vascular access device (VAD) outcome, and self- and family-administered parenteral antimicrobial therapy.

METHOD

Data were extracted from the OPAT Patient Management System and from a patient questionnaire survey.

FINDINGS

1084 completed patient episodes were recorded in 958 patients, rising from 39 episodes in 2014 to 265 in 2019. The number of beds released for further utilisation correspondingly rose from 828 in 2014 to 8462 in 2019. The proportion of patients/family members trained to self-administer rose from 25% to 75%, with clinical cure/improvement of infection remaining high at between 84.6% and 92.8% of patients annually. Serious adverse VAD events remained low throughout. The patient response was generally positive.

CONCLUSION

Nurse empowerment within OPAT can lead to significant improvements and patient benefits, while maintaining clinical outcomes.

摘要

背景

莱斯特大学医院国民保健制度信托基金的门诊肠外抗菌治疗(OPAT)服务迅速扩大,更多地由护士主导。

目的

对 2014 年 7 月 1 日至 2019 年 12 月 31 日期间进行的回顾性研究,以评估 OPAT 扩展对进一步利用的床位释放、临床结果、不良血管通路装置(VAD)结果以及自我和家庭管理的肠外抗菌治疗的影响。

方法

从 OPAT 患者管理系统和患者问卷调查中提取数据。

结果

在 958 名患者中记录了 1084 个完整的患者疗程,从 2014 年的 39 个疗程增加到 2019 年的 265 个疗程。可进一步利用的床位数量相应增加,从 2014 年的 828 张增加到 2019 年的 8462 张。接受自我管理培训的患者/家属比例从 25%上升到 75%,每年患者的临床治愈率/改善率仍保持在 84.6%至 92.8%之间。严重的 VAD 不良事件始终保持低水平。患者的反应普遍是积极的。

结论

OPAT 中的护士赋权可以带来显著的改善和患者获益,同时保持临床结果。

相似文献

1
Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway.最大化自我管理门诊静脉注射抗菌治疗途径的机会。
Br J Nurs. 2021 Jan 28;30(2):S4-S10. doi: 10.12968/bjon.2021.30.2.S4.
2
Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting.在英国环境下,一次性弹性连续输注泵用于门诊患者的肠外抗菌治疗(OPAT)的有效性和安全性。
J Chemother. 2024 Apr;36(2):119-126. doi: 10.1080/1120009X.2023.2277507. Epub 2023 Nov 9.
3
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.门诊患者的肠外抗菌治疗的现状和挑战:叙事性综述。
J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177.
4
Quantifying the Time to Administer Outpatient Parenteral Antimicrobial Therapy: A Missed Opportunity to Compensate for the Value of Infectious Diseases.量化门诊肠外抗菌治疗的时间:弥补感染病价值的错失机会。
Clin Infect Dis. 2024 Aug 16;79(2):348-350. doi: 10.1093/cid/ciae262.
5
Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.比利时三级保健门诊患者抗菌治疗(OPAT)项目的疗效和安全性。
Infection. 2020 Jun;48(3):357-366. doi: 10.1007/s15010-020-01398-4. Epub 2020 Feb 14.
6
Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.门诊胃肠外抗菌治疗(OPAT):对选定患者而言,在家自行给药是否安全?一项针对超过13年的大型队列的回顾性分析
J Antimicrob Chemother. 2007 Aug;60(2):356-62. doi: 10.1093/jac/dkm210. Epub 2007 Jun 11.
7
Impact of an outpatient parenteral antimicrobial treatment (OPAT) as part of a paediatric-specific PROA program.门诊胃肠外抗菌治疗(OPAT)作为儿科特定PROA项目一部分的影响
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr;41(4):230-234. doi: 10.1016/j.eimce.2022.08.004. Epub 2022 Aug 10.
8
[Scaling up Outpatient Parenteral Antimicrobial Therapy (OPAT) service in the Netherlands].[扩大荷兰门诊胃肠外抗菌治疗(OPAT)服务]
Ned Tijdschr Geneeskd. 2023 Mar 8;167:D7149.
9
Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy study.澳大利亚门诊患者的肠外抗菌治疗服务:回顾性比较疗效研究。
Intern Med J. 2021 Oct;51(10):1717-1721. doi: 10.1111/imj.15511.
10
Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.安全网医院出院的未参保患者自我管理门诊抗菌药物输注:一项倾向评分平衡的回顾性队列研究。
PLoS Med. 2015 Dec 15;12(12):e1001922. doi: 10.1371/journal.pmed.1001922. eCollection 2015 Dec.

引用本文的文献

1
Clinical and patient-reported outcomes of self-administered outpatient parenteral antimicrobial treatment (S-OPAT): a scoping review.自我给药门诊胃肠外抗菌治疗(S-OPAT)的临床和患者报告结局:一项范围综述
Infection. 2025 May 12. doi: 10.1007/s15010-025-02549-1.
2
The environmental impact of intravenous antimicrobial therapies: a comparison of OPAT and inpatient administration care pathways.静脉抗菌治疗的环境影响:门诊抗菌治疗(OPAT)与住院给药护理途径的比较
JAC Antimicrob Resist. 2025 Mar 11;7(2):dlaf030. doi: 10.1093/jacamr/dlaf030. eCollection 2025 Apr.